Eicosanoids as a new class of ocular hypotensive agents. 2. Comparison of the apparent mechanism of the ocular hypotensive effects of A and F type prostaglandins.
It has recently been shown that derived prostaglandins (PGs) of the A and B types are much more potent ocular hypotensive agents than primary PGs of the E, F, or D type. The purpose of this study was to determine whether two representatives of these structurally different PGs, namely PGA2 and PGF2 alpha-1-isopropyl ester (PGF2 alpha IE), reduce intraocular pressure (IOP) of the feline eye by similar or dissimilar mechanisms. Aqueous humor flow rate was determined by a fluorophotometric technique, Schiotz electronic tonography was used to measure outflow facility and venomanometry was done to measure episcleral venous pressure. Although at the doses used, both PGF2 alpha IE (2.5 micrograms/eye) and PGA2 (5.0 micrograms/eye) caused significant IOP reduction within 2.5 hr after their topical application, neither caused a significant decrease in aqueous humor flow rate, a significant increase in outflow facility or a change in episcleral venous pressure. It was concluded, therefore, that both of these PGs reduce IOP by an apparently similar mechanism, presumably by increasing uveoscleral outflow.
D000818:Animals; D001082:Aqueous Humor / Q000187:drug effects*; D002415:Cats; D015237:Dinoprost / Q000031:analogs & derivatives*; D007429:Intraocular Pressure / Q000187:drug effects*; D011454:Prostaglandins A / Q000494:pharmacology* / Q000627:therapeutic use; D011461:Prostaglandins F, Synthetic / Q000494:pharmacology* / Q000627:therapeutic use
D011454:Prostaglandins A; D011461:Prostaglandins F, Synthetic; C041158:prostaglandin F2 isopropyl ester; D015237:Dinoprost; C100008:prostaglandin A2